Evidence map›Paper›PMID 35656023›Full record

ReviewOxidative medicine and cellular longevity2022

The Regulation and Characterization of Mitochondrial-Derived Methylmalonic Acid in Mitochondrial Dysfunction and Oxidative Stress: From Basic Research to Clinical Practice.

Yige Liu, Shanjie Wang, Xiaoyuan Zhang, Hengxuan Cai, Jinxin Liu, Shaohong Fang, Bo Yu

Abstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. [Occurrence status and treatment strategies of abnormal growth and development in children with methylmalonic acidemia].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yige Liu *Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Shanjie Wang *Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xiaoyuan ZhangDepartment of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Hengxuan CaiDepartment of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Jinxin LiuDepartment of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Shaohong FangDepartment of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, China.ORCID https://orcid.org/0000-0001-8635-857X
Bo YuDepartment of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, China.ORCID https://orcid.org/0000-0002-2045-8567

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylmalonic acid (MMA) can act as a diagnosis of hereditary methylmalonic acidemia and assess the status of vitamin B12. Moreover, as a new potential biomarker, it has been widely reported to be associated with the progression and prognosis of chronic diseases such as cardiovascular events, renal insufficiency, cognitive impairment, and cancer. MMA accumulation may cause oxidative stress and impair mitochondrial function, disrupt cellular energy metabolism, and trigger cell death. This review primarily focuses on the mechanisms and epidemiology or progression in the clinical study on MMA.

Indexed as

Amino Acid Metabolism, Inborn ErrorsMethylmalonic AcidHumansMitochondriaOxidative StressVitamin B 12 DeficiencyMethylmalonic Acid

Identifiers

PMID35656023
PMCPMC9155905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.